Noninvasive Cancer Diagnostics and Technologies Market by Technique and Therapeutics - Global Industry Analysis & Forecast to 2027
Published On : May 2022 Pages : 154 Category: Medical Devices Report Code : HC053552
Noninvasive Cancer Diagnostics and Technologies Market by Technique (Immunochemistry/Immunoassay, Clinical Chemistry, Molecular Diagnostics, Other) Therapeutics (Lung Cancer, Blood cancer, Solid tumors, Breast Cancer, Others) - Global Industry Analysis & Forecast to 2027
Industry Outlook and Trend Analysis
The Noninvasive Cancer Diagnostics and Technologies Market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period. Noninvasive diagnostics is a procedure for the recognition of disease through fewer amounts of cuts into the body. Noninvasive cancer diagnosing techniques give quick and helpful methodology to noninvasive early discovery of disease and give a significant guide to the clinician and expanded solace to the patient. These advancements decrease the death rate by giving treatment in the beginning time of the illness.
Drivers and Restraints
The expanding pervasiveness of different kinds of malignancy and the development of the maturing populace are the central point driving the development of the noninvasive cancer diagnostic and technologies market. Noninvasive disease conclusion innovations are utilized to recognize lung, breast, blood, and different tumors. Breast cancer holds the biggest offer of the noninvasive disease symptomatic and technologies market. Noninvasive malignant growth demonstrative innovations are picking up significance over regular conclusion because of the expanding occurrence of the ailment.
Regional Insights
Asia-Pacific gives worthwhile chances to the key players working in the in the market because of focal point of key players in the developing economies and improvement in the medicinal services framework.
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
- Affymetrix Inc.
- Precision Therapeutics
- Laboratory Corporation of America Holdings (LabCorp)
- BIOVIEW Inc.
- AVIVA Biosciences Corporation
- A&G Pharmaceutical
- Digene Corporation
- Quest Diagnostics Incorporated Cancer Genetics Inc.,
- Gen-Probe Incorporated
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2017 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Noninvasive Cancer Diagnostics and Technologies Market, By Technique, Estimates and Forecast, 2017-2027 ($Million)
o Immunochemistry/Immunoassay
o Clinical Chemistry
o Molecular Diagnostics
o Other
· Noninvasive Cancer Diagnostics and Technologies Market, By Therapeutics, Estimates and Forecast, 2017-2027 ($Million)
o Lung Cancer
o Blood cancer
o Solid tumors
o Breast Cancer
o Others
· Noninvasive Cancer Diagnostics and Technologies Market, By Key Players
o Affymetrix Inc.
o Precision Therapeutics
o Laboratory Corporation of America Holdings (LabCorp)
o BIOVIEW Inc.
o AVIVA Biosciences Corporation
o A&G Pharmaceutical
o Digene Corporation
o Quest Diagnostics Incorporated Cancer Genetics Inc.,
o Gen-Probe Incorporated
· Noninvasive Cancer Diagnostics and Technologies Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Noninvasive Cancer Diagnostics and Technologies Market, By Country
o U.S. Noninvasive Cancer Diagnostics and Technologies Market
o Canada Noninvasive Cancer Diagnostics and Technologies Market
o Mexico Noninvasive Cancer Diagnostics and Technologies Market
o Europe
§ Europe Noninvasive Cancer Diagnostics and Technologies Market, By Country
o Germany Noninvasive Cancer Diagnostics and Technologies Market
o UK Noninvasive Cancer Diagnostics and Technologies Market
o France Noninvasive Cancer Diagnostics and Technologies Market
o Russia Noninvasive Cancer Diagnostics and Technologies Market
o Italy Noninvasive Cancer Diagnostics and Technologies Market
o Rest of Europe Noninvasive Cancer Diagnostics and Technologies Market
o Asia-Pacific
§ Asia-Pacific Noninvasive Cancer Diagnostics and Technologies Market, By Country
o China Noninvasive Cancer Diagnostics and Technologies Market
o Japan Noninvasive Cancer Diagnostics and Technologies Market
o South Korea Noninvasive Cancer Diagnostics and Technologies Market
o India Noninvasive Cancer Diagnostics and Technologies Market
o Southeast Asia Noninvasive Cancer Diagnostics and Technologies Market
o Rest of Asia-Pacific Noninvasive Cancer Diagnostics and Technologies Market
o South America
§ South America Noninvasive Cancer Diagnostics and Technologies Market
o Brazil Noninvasive Cancer Diagnostics and Technologies Market
o Argentina Noninvasive Cancer Diagnostics and Technologies Market
o Columbia Noninvasive Cancer Diagnostics and Technologies Market
o Rest of South America Noninvasive Cancer Diagnostics and Technologies Market
o Middle East and Africa
§ Middle East and Africa Noninvasive Cancer Diagnostics and Technologies Market
o Saudi Arabia Noninvasive Cancer Diagnostics and Technologies Market
o UAE Noninvasive Cancer Diagnostics and Technologies Market
o Egypt Noninvasive Cancer Diagnostics and Technologies Market
o Nigeria Noninvasive Cancer Diagnostics and Technologies Market
o South Africa Noninvasive Cancer Diagnostics and Technologies Market
o Rest of MEA Noninvasive Cancer Diagnostics and Technologies Market
Table of Contents:
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. SWOT Analysis
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Noninvasive Cancer Diagnostics And Technologies Market, By Technique
5.1. Introduction
5.2. Global Noninvasive Cancer Diagnostics And Technologies Revenue and Market Share by Technique (2017-2027)
5.2.1. Global Noninvasive Cancer Diagnostics And Technologies Revenue and Revenue Share by Technique (2017-2027)
5.3. Immunochemistry/Immunoassay
5.3.1. Global Immunochemistry/Immunoassay Revenue and Growth Rate (2017-2027)
5.4. Clinical Chemistry
5.4.1. Global Clinical Chemistry Revenue and Growth Rate (2017-2027)
5.5. Molecular Diagnostics
5.5.1. Global Molecular Diagnostics Revenue and Growth Rate (2017-2027)
5.6. Other
5.6.1. Global Other Revenue and Growth Rate (2017-2027)
6. Noninvasive Cancer Diagnostics And Technologies Market, By Therapeutics
6.1. Introduction
6.2. Global Noninvasive Cancer Diagnostics And Technologies Revenue and Market Share by Therapeutics (2017-2027)
6.2.1. Global Noninvasive Cancer Diagnostics And Technologies Revenue and Revenue Share by Therapeutics (2017-2027)
6.3. Lung Cancer
6.3.1. Global Lung Cancer Revenue and Growth Rate (2017-2027)
6.4. Blood cancer
6.4.1. Global Blood cancer Revenue and Growth Rate (2017-2027)
6.5. Solid tumors
6.5.1. Global Solid tumors Revenue and Growth Rate (2017-2027)
6.6. Breast Cancer
6.6.1. Global Breast Cancer Revenue and Growth Rate (2017-2027)
6.7. Others
6.7.1. Global Others Revenue and Growth Rate (2017-2027)
7. Noninvasive Cancer Diagnostics And Technologies Market, By Region
7.1. Introduction
7.2. Global Noninvasive Cancer Diagnostics And Technologies Revenue and Market Share by Regions
7.2.1. Global Noninvasive Cancer Diagnostics And Technologies Revenue by Regions (2017-2027)
7.3. North America Noninvasive Cancer Diagnostics And Technologies by Countries
7.3.1. North America Noninvasive Cancer Diagnostics And Technologies Revenue and Growth Rate (2017-2027)
7.3.2. North America Noninvasive Cancer Diagnostics And Technologies Revenue (Million USD) by Countries (2017-2027)
7.3.3. United States
7.3.3.1. United States Noninvasive Cancer Diagnostics And Technologies Revenue (Millions USD) and Growth Rate (2017-2027)
7.3.4. Canada
7.3.4.1. Canada Noninvasive Cancer Diagnostics And Technologies Revenue (Millions USD) and Growth Rate (2017-2027)
7.3.5. Mexico
7.3.5.1. Mexico Noninvasive Cancer Diagnostics And Technologies Revenue (Millions USD) and Growth Rate (2017-2027)
7.4. Europe Noninvasive Cancer Diagnostics And Technologies by Countries
7.4.1. Europe Noninvasive Cancer Diagnostics And Technologies Revenue and Growth Rate (2017-2027)
7.4.2. Europe Noninvasive Cancer Diagnostics And Technologies Revenue (Million USD) by Countries (2017-2027)
7.4.3. Germany
7.4.3.1. Germany Noninvasive Cancer Diagnostics And Technologies Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.4. France
7.4.4.1. France Noninvasive Cancer Diagnostics And Technologies Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.5. UK
7.4.5.1. UK Noninvasive Cancer Diagnostics And Technologies Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.6. Russia
7.4.6.1. Russia Noninvasive Cancer Diagnostics And Technologies Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.7. Italy
7.4.7.1. Italy Noninvasive Cancer Diagnostics And Technologies Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.8. Rest of Europe
7.4.8.1. Rest of Europe Noninvasive Cancer Diagnostics And Technologies Revenue (Millions USD) and Growth Rate (2017-2027)
7.5. Asia-Pacific Noninvasive Cancer Diagnostics And Technologies by Countries
7.5.1. Asia-Pacific Noninvasive Cancer Diagnostics And Technologies Revenue and Growth Rate (2017-2027)
7.5.2. Asia-Pacific Noninvasive Cancer Diagnostics And Technologies Revenue (Million USD) by Countries (2017-2027)
7.5.3. China
7.5.3.1. China Noninvasive Cancer Diagnostics And Technologies Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.4. Japan
7.5.4.1. Japan Noninvasive Cancer Diagnostics And Technologies Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.5. Korea
7.5.5.1. Korea Noninvasive Cancer Diagnostics And Technologies Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.6. India
7.5.6.1. India Noninvasive Cancer Diagnostics And Technologies Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.7. Southeast Asia
7.5.7.1. Southeast Asia Noninvasive Cancer Diagnostics And Technologies Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.8. Rest of Asia-Pacific
7.5.8.1. Rest of Asia-Pacific Noninvasive Cancer Diagnostics And Technologies Revenue (Millions USD) and Growth Rate (2017-2027)
7.6. South America Noninvasive Cancer Diagnostics And Technologies by Countries
7.6.1. South America Noninvasive Cancer Diagnostics And Technologies Revenue and Growth Rate (2017-2027)
7.6.2. South America Noninvasive Cancer Diagnostics And Technologies Revenue (Million USD) by Countries (2017-2027)
7.6.3. Brazil
7.6.3.1. Brazil Noninvasive Cancer Diagnostics And Technologies Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.4. Argentina
7.6.4.1. Argentina Noninvasive Cancer Diagnostics And Technologies Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.5. Columbia
7.6.5.1. Columbia Noninvasive Cancer Diagnostics And Technologies Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.6. Rest of South America
7.6.6.1. Rest of South America Noninvasive Cancer Diagnostics And Technologies Revenue (Millions USD) and Growth Rate (2017-2027)
7.7. Middle East and Africa Noninvasive Cancer Diagnostics And Technologies by Countries
7.7.1. Middle East and Africa Noninvasive Cancer Diagnostics And Technologies Revenue and Growth Rate (2017-2027)
7.7.2. Middle East and Africa Noninvasive Cancer Diagnostics And Technologies Revenue (Million USD) by Countries (2017-2027)
7.7.3. Saudi Arabia
7.7.3.1. Saudi Arabia Noninvasive Cancer Diagnostics And Technologies Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.4. United Arab Emirates
7.7.4.1. United Arab Emirates Noninvasive Cancer Diagnostics And Technologies Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.5. Egypt
7.7.5.1. Egypt Noninvasive Cancer Diagnostics And Technologies Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.6. Nigeria
7.7.6.1. Nigeria Noninvasive Cancer Diagnostics And Technologies Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.7. South Africa
7.7.7.1. South Africa Noninvasive Cancer Diagnostics And Technologies Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.8. Turkey
7.7.8.1. Turkey Noninvasive Cancer Diagnostics And Technologies Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.9. Rest of Middle East and Africa
7.7.9.1. Rest of Middle East and Africa Noninvasive Cancer Diagnostics And Technologies Revenue (Millions USD) and Growth Rate (2017-2027)
8. Company Profiles
8.1. Affymetrix Inc.
8.1.1. Business Overview
8.1.2. Service Portfolio
8.1.3. Strategic Developments
8.1.4. Financial Overview
8.2. Precision Therapeutics
8.2.1. Business Overview
8.2.2. Service Portfolio
8.2.3. Strategic Developments
8.2.4. Financial Overview
8.3. Laboratory Corporation of America Holdings (LabCorp)
8.3.1. Business Overview
8.3.2. Service Portfolio
8.3.3. Strategic Developments
8.3.4. Financial Overview
8.4. BIOVIEW Inc.
8.4.1. Business Overview
8.4.2. Service Portfolio
8.4.3. Strategic Developments
8.4.4. Financial Overview
8.5. AVIVA Biosciences Corporation
8.5.1. Business Overview
8.5.2. Service Portfolio
8.5.3. Strategic Developments
8.5.4. Financial Overview
8.6. A&G Pharmaceutical
8.6.1. Business Overview
8.6.2. Service Portfolio
8.6.3. Strategic Developments
8.6.4. Financial Overview
8.7. Digene Corporation
8.7.1. Business Overview
8.7.2. Service Portfolio
8.7.3. Strategic Developments
8.7.4. Financial Overview
8.8. Quest Diagnostics Incorporated Cancer Genetics Inc.,
8.8.1. Business Overview
8.8.2. Service Portfolio
8.8.3. Strategic Developments
8.8.4. Financial Overview
8.9. Gen-Probe Incorporated
8.9.1. Business Overview
8.9.2. Service Portfolio
8.9.3. Strategic Developments
8.9.4. Financial Overview
9. Global Noninvasive Cancer Diagnostics And Technologies Market Competition, by Manufacturer
9.1. Global Noninvasive Cancer Diagnostics And Technologies Financial Overview by Manufacturer (2017-2017)
9.2. Global Noninvasive Cancer Diagnostics And Technologies Price By Region (2017-2017)
9.3. Top 5 Noninvasive Cancer Diagnostics And Technologies Manufacturer Market Share
9.4. Market Competition Trend
10. Noninvasive Cancer Diagnostics And Technologies Market Forecast (2017-2027)
10.1. Global Noninvasive Cancer Diagnostics And Technologies Revenue (Millions USD) and Growth Rate (2017-2027)
10.2. Noninvasive Cancer Diagnostics And Technologies Market Forecast by Regions (2017-2027)
10.2.1. North America Noninvasive Cancer Diagnostics And Technologies Market Forecast (2017-2027)
10.2.1.1. United States Noninvasive Cancer Diagnostics And Technologies Market Forecast (2017-2027)
10.2.1.2. Canada Noninvasive Cancer Diagnostics And Technologies Market Forecast (2017-2027)
10.2.1.3. Mexico Noninvasive Cancer Diagnostics And Technologies Market Forecast (2017-2027)
10.2.2. Europe Noninvasive Cancer Diagnostics And Technologies Market Forecast (2017-2027)
10.2.2.1. Germany Noninvasive Cancer Diagnostics And Technologies Market Forecast (2017-2027)
10.2.2.2. France Noninvasive Cancer Diagnostics And Technologies Market Forecast (2017-2027)
10.2.2.3. UK Noninvasive Cancer Diagnostics And Technologies Market Forecast (2017-2027)
10.2.2.4. Russia Noninvasive Cancer Diagnostics And Technologies Market Forecast (2017-2027)
10.2.2.5. Italy Noninvasive Cancer Diagnostics And Technologies Market Forecast (2017-2027)
10.2.2.6. Rest of Europe Noninvasive Cancer Diagnostics And Technologies Market Forecast (2017-2027)
10.2.3. Asia-Pacific Noninvasive Cancer Diagnostics And Technologies Market Forecast (2017-2027)
10.2.3.1. China Noninvasive Cancer Diagnostics And Technologies Market Forecast (2017-2027)
10.2.3.2. Japan Noninvasive Cancer Diagnostics And Technologies Market Forecast (2017-2027)
10.2.3.3. Korea Noninvasive Cancer Diagnostics And Technologies Market Forecast (2017-2027)
10.2.3.4. India Noninvasive Cancer Diagnostics And Technologies Market Forecast (2017-2027)
10.2.3.5. Southeast Asia Noninvasive Cancer Diagnostics And Technologies Market Forecast (2017-2027)
10.2.3.6. Rest of Asia-Pacific Noninvasive Cancer Diagnostics And Technologies Market Forecast (2017-2027)
10.2.4. South America Noninvasive Cancer Diagnostics And Technologies Market Forecast (2017-2027)
10.2.4.1. Brazil Noninvasive Cancer Diagnostics And Technologies Market Forecast (2017-2027)
10.2.4.2. Argentina Noninvasive Cancer Diagnostics And Technologies Market Forecast (2017-2027)
10.2.4.3. Columbia Noninvasive Cancer Diagnostics And Technologies Market Forecast (2017-2027)
10.2.4.4. Rest of South America Noninvasive Cancer Diagnostics And Technologies Market Forecast (2017-2027)
10.2.5. Middle East and Africa Noninvasive Cancer Diagnostics And Technologies Market Forecast (2017-2027)
10.2.5.1. Saudi Arabia Noninvasive Cancer Diagnostics And Technologies Market Forecast (2017-2027)
10.2.5.2. United Arab Emirates Noninvasive Cancer Diagnostics And Technologies Market Forecast (2017-2027)
10.2.5.3. Egypt Noninvasive Cancer Diagnostics And Technologies Market Forecast (2017-2027)
10.2.5.4. Nigeria Noninvasive Cancer Diagnostics And Technologies Market Forecast (2017-2027)
10.2.5.5. South Africa Noninvasive Cancer Diagnostics And Technologies Market Forecast (2017-2027)
10.2.5.6. Turkey Noninvasive Cancer Diagnostics And Technologies Market Forecast (2017-2027)
10.2.5.7. Rest of Middle East and Africa Noninvasive Cancer Diagnostics And Technologies Market Forecast (2017-2027)
10.3. Noninvasive Cancer Diagnostics And Technologies Market Forecast by Technique (2017-2027)
10.3.1. Noninvasive Cancer Diagnostics And Technologies Forecast by Technique (2017-2027)
10.3.2. Noninvasive Cancer Diagnostics And Technologies Market Share Forecast by Technique (2017-2027)
10.4. Noninvasive Cancer Diagnostics And Technologies Market Forecast by Therapeutics (2017-2027)
10.4.1. Noninvasive Cancer Diagnostics And Technologies Forecast by Therapeutics (2017-2027)
10.4.2. Noninvasive Cancer Diagnostics And Technologies Market Share Forecast by Therapeutics (2017-2027)
List of Tables
List of Tables and Figures:
Figure United States Noninvasive Cancer Diagnostics And Technologies Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Noninvasive Cancer Diagnostics And Technologies Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Noninvasive Cancer Diagnostics And Technologies Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Noninvasive Cancer Diagnostics And Technologies Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Noninvasive Cancer Diagnostics And Technologies Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Noninvasive Cancer Diagnostics And Technologies Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Noninvasive Cancer Diagnostics And Technologies Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Noninvasive Cancer Diagnostics And Technologies Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Noninvasive Cancer Diagnostics And Technologies Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Noninvasive Cancer Diagnostics And Technologies Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Noninvasive Cancer Diagnostics And Technologies Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Noninvasive Cancer Diagnostics And Technologies Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Noninvasive Cancer Diagnostics And Technologies Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Noninvasive Cancer Diagnostics And Technologies Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Noninvasive Cancer Diagnostics And Technologies Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Noninvasive Cancer Diagnostics And Technologies Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Noninvasive Cancer Diagnostics And Technologies Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Noninvasive Cancer Diagnostics And Technologies Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Noninvasive Cancer Diagnostics And Technologies Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Noninvasive Cancer Diagnostics And Technologies Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Noninvasive Cancer Diagnostics And Technologies Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Noninvasive Cancer Diagnostics And Technologies Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Noninvasive Cancer Diagnostics And Technologies Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Noninvasive Cancer Diagnostics And Technologies Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Noninvasive Cancer Diagnostics And Technologies Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Noninvasive Cancer Diagnostics And Technologies Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Noninvasive Cancer Diagnostics And Technologies Revenue and Revenue Share by Technique (2017-2018)
Figure Global Immunochemistry/Immunoassay Revenue and Growth Rate (2017-2018)
Figure Global Clinical Chemistry Revenue and Growth Rate (2017-2018)
Figure Global Molecular Diagnostics Revenue and Growth Rate (2017-2018)
Figure Global Other Revenue and Growth Rate (2017-2018)
Table Global Noninvasive Cancer Diagnostics And Technologies Revenue and Revenue Share by Therapeutics (2017-2018)
Figure Global Lung Cancer Revenue and Growth Rate (2017-2018)
Figure Global Blood cancer Revenue and Growth Rate (2017-2018)
Figure Global Solid tumors Revenue and Growth Rate (2017-2018)
Figure Global Breast Cancer Revenue and Growth Rate (2017-2018)
Figure Global Others Revenue and Growth Rate (2017-2018)
Table Global Noninvasive Cancer Diagnostics And Technologies Revenue by Regions (2017-2018)
Figure North America Noninvasive Cancer Diagnostics And Technologies Growth Rate (2017-2018)
Figure North America Noninvasive Cancer Diagnostics And Technologies Revenue and Growth Rate (2017-2018)
Figure North America Noninvasive Cancer Diagnostics And Technologies by Countries (2017-2018)
Figure North America Noninvasive Cancer Diagnostics And Technologies Revenue (Million USD) by Countries (2017-2018)
Figure United States Noninvasive Cancer Diagnostics And Technologies Growth Rate (2017-2018)
Figure United States Noninvasive Cancer Diagnostics And Technologies Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Noninvasive Cancer Diagnostics And Technologies Growth Rate (2017-2018)
Figure Canada Noninvasive Cancer Diagnostics And Technologies Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Noninvasive Cancer Diagnostics And Technologies Growth Rate (2017-2018)
Figure Mexico Noninvasive Cancer Diagnostics And Technologies Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Noninvasive Cancer Diagnostics And Technologies Growth Rate (2017-2018)
Figure Europe Noninvasive Cancer Diagnostics And Technologies Revenue and Growth Rate (2017-2018)
Figure Europe Noninvasive Cancer Diagnostics And Technologies by Countries (2017-2018)
Figure Europe Noninvasive Cancer Diagnostics And Technologies Revenue (Million USD) by Countries (2017-2018)
Figure Germany Noninvasive Cancer Diagnostics And Technologies Growth Rate (2017-2018)
Figure Germany Noninvasive Cancer Diagnostics And Technologies Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Noninvasive Cancer Diagnostics And Technologies Growth Rate (2017-2018)
Figure France Noninvasive Cancer Diagnostics And Technologies Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Noninvasive Cancer Diagnostics And Technologies Growth Rate (2017-2018)
Figure UK Noninvasive Cancer Diagnostics And Technologies Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Noninvasive Cancer Diagnostics And Technologies Growth Rate (2017-2018)
Figure Russia Noninvasive Cancer Diagnostics And Technologies Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Noninvasive Cancer Diagnostics And Technologies Growth Rate (2017-2018)
Figure Italy Noninvasive Cancer Diagnostics And Technologies Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Noninvasive Cancer Diagnostics And Technologies Growth Rate (2017-2018)
Figure Rest of Europe Noninvasive Cancer Diagnostics And Technologies Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Noninvasive Cancer Diagnostics And Technologies Growth Rate (2017-2018)
Figure Asia-Pacific Noninvasive Cancer Diagnostics And Technologies Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Noninvasive Cancer Diagnostics And Technologies by Countries (2017-2018)
Figure Asia-Pacific Noninvasive Cancer Diagnostics And Technologies Revenue (Million USD) by Countries (2017-2018)
Figure China Noninvasive Cancer Diagnostics And Technologies Growth Rate (2017-2018)
Figure China Noninvasive Cancer Diagnostics And Technologies Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Noninvasive Cancer Diagnostics And Technologies Growth Rate (2017-2018)
Figure Japan Noninvasive Cancer Diagnostics And Technologies Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Noninvasive Cancer Diagnostics And Technologies Growth Rate (2017-2018)
Figure Korea Noninvasive Cancer Diagnostics And Technologies Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Noninvasive Cancer Diagnostics And Technologies Growth Rate (2017-2018)
Figure India Noninvasive Cancer Diagnostics And Technologies Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Noninvasive Cancer Diagnostics And Technologies Growth Rate (2017-2018)
Figure Southeast Asia Noninvasive Cancer Diagnostics And Technologies Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Noninvasive Cancer Diagnostics And Technologies Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Noninvasive Cancer Diagnostics And Technologies Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Noninvasive Cancer Diagnostics And Technologies Growth Rate (2017-2018)
Figure South America Noninvasive Cancer Diagnostics And Technologies Revenue and Growth Rate (2017-2018)
Figure South America Noninvasive Cancer Diagnostics And Technologies by Countries (2017-2018)
Figure South America Noninvasive Cancer Diagnostics And Technologies Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Noninvasive Cancer Diagnostics And Technologies Growth Rate (2017-2018)
Figure Brazil Noninvasive Cancer Diagnostics And Technologies Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Noninvasive Cancer Diagnostics And Technologies Growth Rate (2017-2018)
Figure Argentina Noninvasive Cancer Diagnostics And Technologies Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Noninvasive Cancer Diagnostics And Technologies Growth Rate (2017-2018)
Figure Columbia Noninvasive Cancer Diagnostics And Technologies Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Noninvasive Cancer Diagnostics And Technologies Growth Rate (2017-2018)
Figure Rest of South America Noninvasive Cancer Diagnostics And Technologies Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Noninvasive Cancer Diagnostics And Technologies Growth Rate (2017-2018)
Figure Middle East and Africa Noninvasive Cancer Diagnostics And Technologies Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Noninvasive Cancer Diagnostics And Technologies by Countries (2017-2018)
Figure Middle East and Africa Noninvasive Cancer Diagnostics And Technologies Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Noninvasive Cancer Diagnostics And Technologies Growth Rate (2017-2018)
Figure Saudi Arabia Noninvasive Cancer Diagnostics And Technologies Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Noninvasive Cancer Diagnostics And Technologies Growth Rate (2017-2018)
Figure United Arab Emirates Noninvasive Cancer Diagnostics And Technologies Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Noninvasive Cancer Diagnostics And Technologies Growth Rate (2017-2018)
Figure Egypt Noninvasive Cancer Diagnostics And Technologies Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Noninvasive Cancer Diagnostics And Technologies Growth Rate (2017-2018)
Figure Nigeria Noninvasive Cancer Diagnostics And Technologies Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Noninvasive Cancer Diagnostics And Technologies Growth Rate (2017-2018)
Figure South Africa Noninvasive Cancer Diagnostics And Technologies Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Noninvasive Cancer Diagnostics And Technologies Growth Rate (2017-2018)
Figure Turkey Noninvasive Cancer Diagnostics And Technologies Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Noninvasive Cancer Diagnostics And Technologies Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Noninvasive Cancer Diagnostics And Technologies Revenue (Millions USD) and Growth Rate (2017-2018)
Table Affymetrix Inc. Noninvasive Cancer Diagnostics And Technologies Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Precision Therapeutics Noninvasive Cancer Diagnostics And Technologies Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Laboratory Corporation of America Holdings (LabCorp) Noninvasive Cancer Diagnostics And Technologies Price, Revenue, Gross Margin and Market Share (2017-2017)
Table BIOVIEW Inc. Noninvasive Cancer Diagnostics And Technologies Price, Revenue, Gross Margin and Market Share (2017-2017)
Table AVIVA Biosciences Corporation Noninvasive Cancer Diagnostics And Technologies Price, Revenue, Gross Margin and Market Share (2017-2017)
Table A&G Pharmaceutical Noninvasive Cancer Diagnostics And Technologies Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Digene Corporation Noninvasive Cancer Diagnostics And Technologies Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Quest Diagnostics Incorporated Cancer Genetics Inc., Noninvasive Cancer Diagnostics And Technologies Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Gen-Probe Incorporated Noninvasive Cancer Diagnostics And Technologies Price, Revenue, Gross Margin and Market Share (2017-2017)
Figure Global Noninvasive Cancer Diagnostics And Technologies Market Share by Manufacturer
Figure Global Noninvasive Cancer Diagnostics And Technologies Revenue and Market Share by Manufacturer
Table Global Noninvasive Cancer Diagnostics And Technologies Price by Region (2017-2017)
Figure Top 5 Noninvasive Cancer Diagnostics And Technologies Manufacturer (Revenue) Market Share
Figure Market Competition Trend
Figure Global Noninvasive Cancer Diagnostics And Technologies Revenue (Millions USD) and Growth Rate (2018-2025)
Table Noninvasive Cancer Diagnostics And Technologies Market Forecast by Regions (2018-2025)
Figure North America Noninvasive Cancer Diagnostics And Technologies Market Forecast (2018-2025)
Figure United States Noninvasive Cancer Diagnostics And Technologies Market Forecast (2018-2025)
Figure Canada Noninvasive Cancer Diagnostics And Technologies Market Forecast (2018-2025)
Figure Mexico Noninvasive Cancer Diagnostics And Technologies Market Forecast (2018-2025)
Figure Europe Noninvasive Cancer Diagnostics And Technologies Market Forecast (2018-2025)
Figure Germany Noninvasive Cancer Diagnostics And Technologies Market Forecast (2018-2025)
Figure France Noninvasive Cancer Diagnostics And Technologies Market Forecast (2018-2025)
Figure UK Noninvasive Cancer Diagnostics And Technologies Market Forecast (2018-2025)
Figure Russia Noninvasive Cancer Diagnostics And Technologies Market Forecast (2018-2025)
Figure Italy Noninvasive Cancer Diagnostics And Technologies Market Forecast (2018-2025)
Figure Rest of Europe Noninvasive Cancer Diagnostics And Technologies Market Forecast (2018-2025)
Figure Asia-Pacific Noninvasive Cancer Diagnostics And Technologies Market Forecast (2018-2025)
Figure China Noninvasive Cancer Diagnostics And Technologies Market Forecast (2018-2025)
Figure Japan Noninvasive Cancer Diagnostics And Technologies Market Forecast (2018-2025)
Figure Korea Noninvasive Cancer Diagnostics And Technologies Market Forecast (2018-2025)
Figure India Noninvasive Cancer Diagnostics And Technologies Market Forecast (2018-2025)
Figure Southeast Asia Noninvasive Cancer Diagnostics And Technologies Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Noninvasive Cancer Diagnostics And Technologies Market Forecast (2018-2025)
Figure South America Noninvasive Cancer Diagnostics And Technologies Market Forecast (2018-2025)
Figure Brazil Noninvasive Cancer Diagnostics And Technologies Market Forecast (2018-2025)
Figure Argentina Noninvasive Cancer Diagnostics And Technologies Market Forecast (2018-2025)
Figure Columbia Noninvasive Cancer Diagnostics And Technologies Market Forecast (2018-2025)
Figure Rest of South America Noninvasive Cancer Diagnostics And Technologies Market Forecast (2018-2025)
Figure Middle East and Africa Noninvasive Cancer Diagnostics And Technologies Market Forecast (2018-2025)
Figure Saudi Arabia Noninvasive Cancer Diagnostics And Technologies Market Forecast (2018-2025)
Figure United Arab Emirates Noninvasive Cancer Diagnostics And Technologies Market Forecast (2018-2025)
Figure Egypt Noninvasive Cancer Diagnostics And Technologies Market Forecast (2018-2025)
Figure Nigeria Noninvasive Cancer Diagnostics And Technologies Market Forecast (2018-2025)
Figure South Africa Noninvasive Cancer Diagnostics And Technologies Market Forecast (2018-2025)
Figure Turkey Noninvasive Cancer Diagnostics And Technologies Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Noninvasive Cancer Diagnostics And Technologies Market Forecast (2018-2025)
Figure Global Noninvasive Cancer Diagnostics And Technologies Forecast by Technique (2018-2025)
Figure Global Noninvasive Cancer Diagnostics And Technologies Market Share Forecast by Technique (2018-2025)
Figure Global Noninvasive Cancer Diagnostics And Technologies Forecast by Technique (2018-2025)
Figure Global Noninvasive Cancer Diagnostics And Technologies Forecast by Therapeutics (2018-2025)
Figure Global Noninvasive Cancer Diagnostics And Technologies Market Share Forecast by Therapeutics (2018-2025)
Figure Global Noninvasive Cancer Diagnostics And Technologies Forecast by Therapeutics (2018-2025)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|